News Quantified

KOD – kodiak sciences inc (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Kodiak Sciences (NASDAQ:KOD) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.

Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026 [Yahoo! Finance]

Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026

Kodiak Sciences: A Stellar Move [Seeking Alpha]

Kodiak Sciences (NASDAQ:KOD) had its "buy" rating reaffirmed by analysts at HC Wainwright.

3.4%

MISS

16.5%

MISS

-4.9%

BEAT

Form SCHEDULE 13D/A Kodiak Sciences Inc. Filed by: BAKER BROS. ADVISORS LP

Form 4 Kodiak Sciences Inc. For: Dec 18 Filed by: Baker Brothers Life Sciences LP

Form 8-K Kodiak Sciences Inc. For: Dec 16

Form 424B5 Kodiak Sciences Inc.

Form 424B5 Kodiak Sciences Inc.

Top News Gainers

12/2 Kodiak Sciences Announces Sale of Future Royalties on KSI-301 for $225 Million to Baker Bros. Advisors 72.5%

12/4 Kodiak Sciences prices $276M equity offering [Seeking Alpha] 49.8%

9/15 Kodiak Sciences Announces Emerging Durability Data from Ongoing Phase 1b Study of KSI-301 in Wet AMD Patients at The Retina Society Annual Meeting 17.2%

11/15 Form EFFECT Kodiak Sciences Inc. 16.6%

12/24 Kodiak Sciences Inc. (NYSE: KOD) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $82.00 price target on the stock. 15.3%

10/10 Form 8-K Kodiak Sciences Inc. For: Oct 04 13.3%

3/18 Form 4 Kodiak Sciences Inc. For: Mar 16 Filed by: BAKER FELIX 12.5%

5/15 Form S-8 Kodiak Sciences Inc. 12.2%

4/29 Form DEFA14A Kodiak Sciences Inc. 9.1%

9/4 Kodiak Sciences Announces Upcoming Presentations at EURETINA Meeting 8.3%

Top News Decliners

3/16 Q4/2019 12/31/2019 EPS -0.400 ZacksConsensus N/A ActVsEst N/A - N/A -24.2%

12/4 Form 4 Kodiak Sciences Inc. For: Dec 02 Filed by: Liang Hong -11.0%

11/20 Form 8-K Kodiak Sciences Inc. For: Nov 18 -10.5%

8/14 Q2/2019 6/30/2019 EPS -0.310 ZacksConsensus N/A ActVsEst N/A - N/A -9.9%

2/26 Form SC 13D/A Kodiak Sciences Inc. Filed by: BAKER BROS. ADVISORS LP -8.4%

4/6 Form 4 Kodiak Sciences Inc. For: Apr 02 Filed by: Liang Hong -8.2%

12/2 Kodiak Sciences Inc. (NYSE: KOD) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $40.00 price target on the stock. -7.9%

4/22 Form 4 Kodiak Sciences Inc. For: Apr 20 Filed by: EHRLICH JASON -6.9%

11/12 Q3/2019 9/30/2019 EPS -0.330 ZacksConsensus -0.330 ActVsEst 0.000 - In-Line -6.1%

11/18 3 Biotech Stock Rockets With More Fuel in the Tank [The Motley Fool] -5.6%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day